πŸ‡ΊπŸ‡Έ FDA
Patent

US 10604535

Compounds, compositions and methods

granted A61PA61P1/02A61P1/04

Quick answer

US patent 10604535 (Compounds, compositions and methods) held by DENALI THERAPEUTICS INC. expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DENALI THERAPEUTICS INC.
Grant date
Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18